durvalumab,Tremelimumab
AstraZeneca
$azn astrazeneca shares data at easl and esmo world gi for imfinzi combinations in patients with liver and biliary tract cancers 
Actionable Global Markets Newswire. Built for Traders, by Traders.

Click the Website Link to Sign up for fast, immediate accesss!